Daiwa Securities Group’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-225
| Closed | -$29K | – | 1339 |
|
|
2025
Q2 | $29K | Buy |
225
+15
| +7% | +$1.56K | ﹤0.01% | 1088 |
|
|
2025
Q1 | $19K | Hold |
210
| – | – | ﹤0.01% | 1071 |
|
|
2024
Q4 | $18K | Sell |
210
-27
| -11% | -$2.47K | ﹤0.01% | 1087 |
|
|
2024
Q3 | $22K | Hold |
237
| – | – | ﹤0.01% | 1095 |
|
|
2024
Q2 | $26K | Sell |
237
-4
| -2% | -$400 | ﹤0.01% | 1122 |
|
|
2024
Q1 | $23K | Hold |
241
| – | – | ﹤0.01% | 1132 |
|
|
2023
Q4 | $22K | Hold |
241
| – | – | ﹤0.01% | 1116 |
|
|
2023
Q3 | $12K | Hold |
241
| – | – | ﹤0.01% | 1117 |
|
|
2023
Q2 | $15K | Hold |
241
| – | – | ﹤0.01% | 1120 |
|
|
2023
Q1 | $11K | Hold |
241
| – | – | ﹤0.01% | 1105 |
|
|
2022
Q4 | $11K | Buy |
241
+19
| +9% | +$911 | ﹤0.01% | 1108 |
|
|
2022
Q3 | $15K | Hold |
222
| – | – | ﹤0.01% | 1107 |
|
|
2022
Q2 | $11K | Buy |
222
+50
| +29% | +$2.93K | ﹤0.01% | 1136 |
|
|
2022
Q1 | $11K | Hold |
172
| – | – | ﹤0.01% | 1132 |
|
|
2021
Q4 | $18K | Sell |
172
-29
| -14% | -$3.03K | ﹤0.01% | 1121 |
|
|
2021
Q3 | $21K | Buy |
201
+86
| +75% | +$8.01K | ﹤0.01% | 1099 |
|
|
2021
Q2 | $10K | Hold |
115
| – | – | ﹤0.01% | 1046 |
|
|
2021
Q1 | $11K | Buy |
115
+10
| +10% | +$998 | ﹤0.01% | 1041 |
|
|
2020
Q4 | $12K | Sell |
105
-204
| -66% | -$21.5K | ﹤0.01% | 1006 |
|
|
2020
Q3 | $29K | Buy |
309
+8
| +3% | +$616 | ﹤0.01% | 966 |
|
|
2020
Q2 | $18K | Hold |
301
| – | – | ﹤0.01% | 1026 |
|
|
2020
Q1 | $18K | Buy |
301
+23
| +8% | +$1.48K | ﹤0.01% | 1011 |
|
|
2019
Q4 | $22K | Sell |
278
-35
| -11% | -$2.62K | ﹤0.01% | 1005 |
|
|
2019
Q3 | $23K | Buy |
313
+6
| +2% | +$519 | ﹤0.01% | 990 |
|
|
2019
Q2 | $29K | Buy |
307
+27
| +10% | +$2.23K | ﹤0.01% | 991 |
|
|
2019
Q1 | $22K | Buy |
280
+40
| +17% | +$2.96K | ﹤0.01% | 987 |
|
|
2018
Q4 | $13K | Hold |
240
| – | – | ﹤0.01% | 986 |
|
|
2018
Q3 | $19K | Hold |
240
| – | – | ﹤0.01% | 1004 |
|
|
2018
Q2 | $15K | Hold |
240
| – | – | ﹤0.01% | 1022 |
|
|
2018
Q1 | $22K | Buy |
+240
| New | +$20.7K | ﹤0.01% | 988 |
|
Other funds holding BPMC
IA
HNB
Daiwa Securities Group's BPMC Position: Q3 2025 in Review
Daiwa Securities Group sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 225 shares — an estimated $29K sold.
Daiwa Securities Group first reported a position in BPMC in Q1 2018 and held it in 30 quarters. The position peaked at $29K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Daiwa Securities Group reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Daiwa Securities Group sold 225 Blueprint Medicines shares in Q3 2025, an estimated $29K.
- Daiwa Securities Group first reported a position in Blueprint Medicines in Q1 2018 and held it in 30 quarters.
- Daiwa Securities Group's Blueprint Medicines position peaked at $29K in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Daiwa Securities Group's 13F filing for Q3 2025, filed 14 Nov 2025.